Effect of warfarin nonadherence on control of the International Normalized Ratio

被引:74
作者
Waterman, AD
Milligan, PE
Bayer, L
Banet, GA
Gatchel, SK
Gage, BF
机构
[1] Washington Univ, Sch Med, Div Gen Med Sci, St Louis, MO 63110 USA
[2] Comprehens Neuropsychol Serv, Cheshire, CT USA
[3] Washington Univ, Sch Med, Div Emergency Med, St Louis, MO 63110 USA
关键词
age; anticoagulants; compliance; geriatrics; International Normalized Ratio; patients; warfarin;
D O I
10.1093/ajhp/61.12.1258
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective. The frequency and causes of aberrant International Normalized Ratios (INRs) in warfarin recipients and the percentage explainable by warfarin nonadherence were studied. Methods. The medical records of patients whose warfarin therapy was monitored by a telephone-based anticoagulation service in a Midwestern urban hospital between March 2000 and March 2001 were reviewed for causes of out-of-range INRs, the percentage of out-of-range INRs attributable to warfarin nonadherence, and demographic and clinical variables predictive of nonadherence. Results. Data from 347 patients were studied. The cohort yielded 4305 INRs, of which 1002 (23%) were out of range (lower than 1.8 or higher than 3.4). Thirty-six percent of the out-of-range INRs were due to warfarin or dietary nonadherence, 9% were due to medical systems problems (including drug interactions), 18% were due to a change in clinical status, and 38% were idiopathic. Age younger than 65 years, age greater than 80 years, and living closer to the laboratory were predictive of warfarin nonadherence. Conclusion. Warfarin nonadherence was the most common cause of explainable aberrant INRs in patients taking warfarin. Age younger than 65 years, age greater than 80 years, and living close to the laboratory were predictive of warfarin nonadherence.
引用
收藏
页码:1258 / 1264
页数:7
相关论文
共 51 条
  • [1] Managing oral anticoagulant therapy
    Ansell, J
    Hirsh, J
    Dalen, J
    Bussey, H
    Anderson, D
    Poller, L
    Jacobson, A
    Deykin, D
    Matchar, D
    [J]. CHEST, 2001, 119 (01) : 22S - 38S
  • [2] Determinants of compliance with anticoagulation: A case-control study
    Arnsten, JH
    Gelfand, JM
    Singer, DE
    [J]. AMERICAN JOURNAL OF MEDICINE, 1997, 103 (01) : 11 - 17
  • [3] Warfarin dose reduction vs watchful waiting for mild elevations in the international normalized ratio
    Banet, GA
    Waterman, AD
    Milligan, PE
    Gatchel, SK
    Gage, BF
    [J]. CHEST, 2003, 123 (02) : 499 - 503
  • [4] Patient factors and medication guideline adherence among older women with asthma
    Barr, RG
    Somers, SC
    Speizer, FE
    Camargo, CA
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (15) : 1761 - 1768
  • [5] A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin - A randomized, controlled trial
    Beyth, RJ
    Quinn, L
    Landefeld, CS
    [J]. ANNALS OF INTERNAL MEDICINE, 2000, 133 (09) : 687 - 695
  • [6] Brigden ML, 1998, AM J HEMATOL, V59, P22, DOI 10.1002/(SICI)1096-8652(199809)59:1<22::AID-AJH5>3.3.CO
  • [7] 2-J
  • [8] CALCAGNO D, 1996, AM J MANAG CARE, V2, P804
  • [9] OPTIMAL ORAL ANTICOAGULANT-THERAPY IN PATIENTS WITH MECHANICAL HEART-VALVES
    CANNEGIETER, SC
    ROSENDAAL, FR
    WINTZEN, AR
    VANDERMEER, FJM
    VANDENBROUCKE, JP
    BRIET, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (01) : 11 - 17
  • [10] Casais P, 2000, AM J HEMATOL, V63, P192, DOI 10.1002/(SICI)1096-8652(200004)63:4<192::AID-AJH5>3.0.CO